ERBB2 and breast neoplasm: The IRF1 pleiotropic activity is indicated by the increased expression of IRF1 in HER2+ breast tumor basal cells (Table 4 and Table 5) that in contrast to FB2 cells, were associated with the IL6-JAK-STAT3 signaling pathway.